Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.

Active substance factsheet - Last updated: 26/08/2019

Active substance

EC number:

433-460-1

CAS number:

210880-92-5

IUPAC name:

(E)-N'-[(2-chloro-1,3-thiazol-5-yl)methyl]-N-methyl-N''-nitroguanidine

BAS number:

15

Product-type:

PT18

Candidate for substitution:

Yes

Regulatory Process:

Review programme substance

Approval/Assessment status:

Approved

Related authorised biocidal products

1 related product

-

CLOTHIANIDIN RB1

MAXFORCE PLATIN

Belgium

Denmark

France

Germany

Luxembourg

Slovenia

Sweden

United Kingdom

National authorisation Link to the factsheet
Approval data details
Administrative identifiers

Evaluating competent authority:

Germany

R4BP asset number:

EU-0012168-0000

Approval identifiers
Validity of approval

Start date:

01/10/2016

End date:

30/09/2026

Documents
Assessment Reports

Assessment Report

Study summaries (Document III-A)
Other documents
Amendment of active substance - Conclusion Date: 11/04/2019
Assessment information

Evaluating competent authority:

European Commission

Assessment outcome:

Successful

Conclusion date:

11/04/2019

Validity of approval

Start date:

01/10/2016

End date:

30/09/2026

Documents
Assessment Reports

Assessment Report

Study summaries (Document III-A)
Other documents
Amendment of active substance - Conclusion Date: 24/07/2015
Assessment information

Evaluating competent authority:

European Commission

Assessment outcome:

Successful

Conclusion date:

24/07/2015

Validity of approval

Start date:

01/10/2016

End date:

30/09/2026

Documents
Assessment Reports

Assessment Report

Study summaries (Document III-A)
Other documents
Approval of active substance - Conclusion Date: 14/07/2015
Assessment information

Evaluating competent authority:

Germany

Assessment outcome:

Successful

Conclusion date:

14/07/2015

Validity of approval

Start date:

01/10/2016

End date:

30/09/2026

Documents
Assessment Reports
Study summaries (Document III-A)
Other documents